Who Owns IMDX?

Insight Molecular Diagnostics Inc. — Institutional Ownership & 13F Holdings

$3.97

+0.14 (+3.66%)

Market Cap

$154.8M

Shares Outstanding

26,841,463

Institutional Holders

29

Total Inst. Value

$49.1M

% of Float Held

QoQ Holder Change

+8

Institutional data as of Q1 2025

New Positions

11

Closed Positions

5

Increased

8

Decreased

4

Institutional Ownership Trend

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1BROADWOOD CAPITAL INC$34.9M11,410,100
2AWM Investment Company, Inc.$8.6M2,822,530
3PURA VIDA INVESTMENTS, LLC$2.9M947,134
4VANGUARD GROUP INC$812K265,457
5GEODE CAPITAL MANAGEMENT, LLC$486K158,907
6BlackRock, Inc.$244K79,585
7WEALTHEDGE INVESTMENT ADVISORS, LLC$226K73,971
8MORGAN STANLEY$188K61,708
9CITADEL ADVISORS LLCNew$149K48,784
10SUSQUEHANNA INTERNATIONAL GROUP, LLPNew$137K44,806

Biggest Buyers & Sellers This Quarter

Top Sellers

Related Stocks

Frequently Asked Questions

How many institutional investors hold IMDX?

As of Q1 2025, 29 institutional investors report holding IMDX (Insight Molecular Diagnostics Inc.) in their 13F filings.

Which hedge fund owns the most IMDX?

The largest institutional holder of IMDX is BROADWOOD CAPITAL INC with $34.9M in shares.

Are institutions buying or selling IMDX?

This quarter, 11 institutions opened new positions in IMDX and 5 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.